SEOUL, Nov. 18 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc.’s coronavirus treatment is likely to file for emergency authorization use from local drug authorities next month, the company’s chief said Wednesday. CT-P59, anti-COVID-19 monoclonal antibody treatment, is currently undergoing a phase two clinical trial locally after successfully completing a phase one clinical trial [...]
SEOUL, Nov. 18 (Korea Bizwire) — A number of major South Korean pharmaceutical companies have recently signed a series of deals to manufacture vaccines and treatment drugs for the novel coronavirus, industry watchers said Wednesday. Among the front-runners is industry leader Samsung Biologics Co., which successfully inked two contract manufacturing organization (CMO) agreements this year. [...]
SEOUL, Nov. 17 (Korea Bizwire) — South Korean pharmaceutical firm Samsung Biologics Co. said Tuesday it has signed a long-term agreement with U.S. pharmaceutical firm Eli Lilly and Company to manufacture a novel coronavirus-neutralizing antibody. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will provide Eli Lilly’s investigational neutralizing antibody for the treatment of [...]
SEOUL, Nov. 13 (Korea Bizwire) — A South Korean research team has developed the technology and equipment to detect viruses in an indoor environment in just 50 minutes. A joint research team from the Korea Institute of Science and Technology, the Gwangju Institute of Science and Technology, and Konkuk University’s Department of Veterinary Medicine announced [...]
SEOUL, Nov. 13 (Korea Bizwire) — South Korean bio company GL Rapha will produce over 150 million annual doses of Russia’s COVID-19 vaccine for global distribution, Russia’s sovereign wealth fund said Friday. The Russian Direct Investment Fund (RDIF) said GL Rapha will begin manufacturing Sputnik V in South Korea next month, which it described “the [...]
SEOUL, Nov. 13 (Korea Bizwire) — A recent study has revealed that artificial intelligence (AI) can predict the mutation of genes. If this technology is commercialized, it could contribute to identifying the cause of genetic diseases and curing them promptly. A joint research team composed of researchers from the Gangnam Severance Hospital and the Asan [...]
SEOUL, Nov. 11 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc.’s COVID-19 treatment kills the coronavirus within 4-5 days, effectively protecting patients with mild symptoms from developing a severe case, the company’s chief said Wednesday. Celltrion Group Chairman Seo Jung-jin said the first stage trial of CT-P59, anti-COVID-19 monoclonal antibody treatment, shortened the recovery [...]
SEOUL, Nov. 11 (Korea Bizwire) — In collaboration with the Korea University Medical Center (KUMC), the Hyundai Motor Chung Mong-Koo Foundation will roll out the nation’s first computed tomography (CT) checkup bus for the diagnosis of COVID-19. The foundation held a ceremony for the signing of an agreement with the KUMC on Monday to develop [...]
DAEJEON, Nov. 10 (Korea Bizwire) — A research team consisting of local and international staff has mathematically identified the reason why obesity causes sleep disorder. A joint research team set up by the Korea Advanced Institute of Science and Technology (KAIST) and the Florida State University announced on Monday that they had identified the principle of [...]
SEOUL, Nov. 9 (Korea Bizwire) — Samsung Electronics Co. said Monday its laboratory has been recognized as an international institute to verify microbial-related tests, boosting its capability to analyze antibacterial performance on its products. Samsung’s Eco-Life Lab was accredited by TUV Rheinland AG, a German-based technical test service and certification organization, with two International Organization [...]